Feedback / Questions
MOv18 IgE - Epsilogen, Cancer Research UK
https://www.businesswire.com/news/home/20240305297151/en/Epsilogen-and-Lonza-Announce-Successful-Large-Scale-GMP-Manufacturing-of-MOv18-an-IgE-Antibody-Targeting-Ovarian-Cancer
Mar 5, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next